Carlos Cervera, Associate Professor

Assistant Professor
University of Alberta, Canada

Disclosure(s): Astra-Zeneca: Advisor/Consultant; AVIR Pharma: Grant/Research Support, Honoraria; Lilly: Advisor/Consultant; Merck: Advisor/Consultant, Grant/Research Support, Honoraria; Sunovion: Advisor/Consultant; Takeda: Advisor/Consultant, Honoraria; VerityPharma: Advisor/Consultant

Poster(s):

• 2104 - Cytomegalovirus DNAemia Patterns in Mismatched Solid Organ Transplant Recipients: A Retrospective Cohort Study.
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2111 - Impact of Colonization by Multi Drug Resistant Bacteria on Graft Survival, Risk of Infection, and Mortality in Recipients of Solid Organ Transplant: Systematic Review and Meta-analysis
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET